BiosanaPharma

Over BiosanaPharma

BiosanaPharma has developed a highly flexible, comprehensive Continuous Manufacturing (CM) automation platform, suitable for all relevant GMP production scales (50L, 500L, and 2000L). Our 3C platform is unit operation-independent, and with integrated automatic sampling and on/at-line analytical, a continuous downstream process (DSP) can be fully implemented within 12 to 18 months.”

Trefwoorden

• Biosimilar Mabs
• Biotechnology
• Low Cost Of Goods
• Monoclonal Antibodies

Team per functiegebied

Gebaseerd op 2 openbare functieprofielen, stand van 19 september 2026.

• Executive / C-Suite1
• Other / Unclassifiable1